Year |
Citation |
Score |
2024 |
Wang Y, Hu M, Finn OJ, Wang XS. Tumor-Associated Antigen Burden Correlates with Immune Checkpoint Blockade Benefit in Tumors with Low Levels of T-cell Exhaustion. Cancer Immunology Research. PMID 39137006 DOI: 10.1158/2326-6066.CIR-23-0932 |
0.412 |
|
2024 |
Wang Y, Li S, Hu M, Yang Y, McCabe E, Zhang L, Withrow AM, Ting JP, Liu R. Universal STING mimic boosts antitumour immunity via preferential activation of tumour control signalling pathways. Nature Nanotechnology. PMID 38480836 DOI: 10.1038/s41565-024-01624-2 |
0.311 |
|
2023 |
Hu M, Kenific CM, Boudreau N, Lyden D. Tumor-derived nanoseeds condition the soil for metastatic organotropism. Seminars in Cancer Biology. PMID 37178822 DOI: 10.1016/j.semcancer.2023.05.003 |
0.311 |
|
2022 |
Li Z, Low V, Luga V, Sun J, Earlie E, Parang B, Shobana Ganesh K, Cho S, Endress J, Schild T, Hu M, Lyden D, Jin W, Guo C, Dephoure N, et al. Tumor-produced and aging-associated oncometabolite methylmalonic acid promotes cancer-associated fibroblast activation to drive metastatic progression. Nature Communications. 13: 6239. PMID 36266345 DOI: 10.1038/s41467-022-33862-0 |
0.321 |
|
2022 |
Liu X, Zhou J, Wu H, Chen S, Zhang L, Tang W, Duan L, Wang Y, McCabe E, Hu M, Yu Z, Liu H, Choi CHJ, Sung JJ, Huang L, et al. Fibrotic immune microenvironment remodelling mediates superior anti-tumor efficacy of a nano-PD-L1 trap in hepatocellular carcinoma. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 36146933 DOI: 10.1016/j.ymthe.2022.09.012 |
0.537 |
|
2022 |
Hu M, Huang L. Strategies targeting tumor immune and stromal microenvironment and their clinical relevance. Advanced Drug Delivery Reviews. 183: 114137. PMID 35143893 DOI: 10.1016/j.addr.2022.114137 |
0.486 |
|
2021 |
Sendi H, Yazdimamaghani M, Hu M, Sultanpuram N, Wang J, Moody AS, McCabe E, Zhang J, Graboski A, Li L, Rojas JD, Dayton PA, Huang L, Wang AZ. Nanoparticle delivery of miR-122 inhibits colorectal cancer liver metastasis. Cancer Research. PMID 34753773 DOI: 10.1158/0008-5472.CAN-21-2269 |
0.454 |
|
2021 |
Qiu N, Liu Y, Liu Q, Chen Y, Shen L, Hu M, Zhou X, Shen Y, Gao J, Huang L. Corrigendum to "Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapy" [Biomaterials 269 (2021) 120604]. Biomaterials. 277: 121121. PMID 34507130 DOI: 10.1016/j.biomaterials.2021.121121 |
0.434 |
|
2021 |
Wang Y, Tiruthani K, Li S, Hu M, Zhong G, Tang Y, Roy S, Zhang L, Tan J, Liao C, Liu R. mRNA Delivery of a Bispecific Single-Domain Antibody to Polarize Tumor-Associated Macrophages and Synergize Immunotherapy against Liver Malignancies. Advanced Materials (Deerfield Beach, Fla.). e2007603. PMID 33945178 DOI: 10.1002/adma.202007603 |
0.429 |
|
2021 |
Zhou X, Liu Y, Hu M, Wang M, Liu X, Huang L. Relaxin gene delivery modulates macrophages to resolve cancer fibrosis and synergizes with immune checkpoint blockade therapy. Science Advances. 7. PMID 33597232 DOI: 10.1126/sciadv.abb6596 |
0.656 |
|
2021 |
Hu M, Wang Y, Liu Z, Yu Z, Guan K, Liu M, Wang M, Tan J, Huang L. Hepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis. Nature Nanotechnology. PMID 33495618 DOI: 10.1038/s41565-020-00836-6 |
0.589 |
|
2020 |
Qiu N, Liu Y, Liu Q, Chen Y, Shen L, Hu M, Zhou X, Shen Y, Gao J, Huang L. Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapy. Biomaterials. 269: 120604. PMID 33383300 DOI: 10.1016/j.biomaterials.2020.120604 |
0.586 |
|
2020 |
Yu Z, Guo J, Hu M, Gao Y, Huang L. Icaritin Exacerbates Mitophagy and Synergizes with Doxorubicin to Induce Immunogenic Cell Death in Hepatocellular Carcinoma. Acs Nano. PMID 32188241 DOI: 10.1021/Acsnano.0C00708 |
0.503 |
|
2020 |
Xu H, Hu M, Liu M, An S, Guan K, Wang M, Li L, Zhang J, Li J, Huang L. Nano-puerarin regulates tumor microenvironment and facilitates chemo- and immunotherapy in murine triple negative breast cancer model. Biomaterials. 235: 119769. PMID 31986348 DOI: 10.1016/J.Biomaterials.2020.119769 |
0.648 |
|
2020 |
Xiong Y, Song W, Shen L, Wang Y, Zhang J, Hu M, Liu Y, Li J, Musetti S, Liu R, Huang L. Oral Metformin and Polymetformin Reprogram Immunosuppressive Microenvironment and Boost Immune Checkpoint Inhibitor Therapy in Colorectal Cancer Advanced Therapeutics. 3: 2000168. DOI: 10.1002/adtp.202000168 |
0.619 |
|
2019 |
Hu M, Zhou X, Wang Y, Guan K, Huang L. Relaxin-FOLFOX-IL-12 triple combination therapy engages memory response and achieves long-term survival in colorectal cancer liver metastasis. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 31899270 DOI: 10.1016/J.Jconrel.2019.12.053 |
0.467 |
|
2019 |
Hu M, Wang Y, Xu L, An S, Tang Y, Zhou X, Li J, Liu R, Huang L. Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy. Nature Communications. 10: 2993. PMID 31278269 DOI: 10.1038/S41467-019-10893-8 |
0.541 |
|
2019 |
An S, Tiruthani K, Wang Y, Xu L, Hu M, Li J, Song W, Jiang H, Sun J, Liu R, Huang L. Locally Trapping the C-C Chemokine Receptor Type 7 by Gene Delivery Nanoparticle Inhibits Lymphatic Metastasis Prior to Tumor Resection. Small (Weinheim An Der Bergstrasse, Germany). e1805182. PMID 30690891 DOI: 10.1002/Smll.201805182 |
0.525 |
|
2019 |
Chen Y, Song W, Shen L, Qiu N, Hu M, Liu Y, Liu Q, Huang L. Vasodilator Hydralazine Promotes Nanoparticle Penetration in Advanced Desmoplastic Tumor. Acs Nano. PMID 30642161 DOI: 10.1021/acsnano.8b07830 |
0.46 |
|
2018 |
Sun H, Yang W, Tian Y, Zeng X, Zhou J, Mok MTS, Tang W, Feng Y, Xu L, Chan AWH, Tong JH, Cheung YS, Lai PBS, Wang HKS, Tsang SW, ... ... Hu M, et al. An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma. Nature Communications. 9: 5214. PMID 30523261 DOI: 10.1038/S41467-018-07402-8 |
0.379 |
|
2018 |
Song W, Tiruthani K, Wang Y, Shen L, Hu M, Dorosheva O, Qiu K, Kinghorn KA, Liu R, Huang L. Trapping of Lipopolysaccharide to Promote Immunotherapy against Colorectal Cancer and Attenuate Liver Metastasis. Advanced Materials (Deerfield Beach, Fla.). e1805007. PMID 30387230 DOI: 10.1002/adma.201805007 |
0.506 |
|
2017 |
Goodwin TJ, Shen L, Hu M, Li J, Feng R, Dorosheva O, Liu R, Huang L. Liver specific gene immunotherapies resolve immune suppressive ectopic lymphoid structures of liver metastases and prolong survival. Biomaterials. 141: 260-271. PMID 28700955 DOI: 10.1016/j.biomaterials.2017.07.007 |
0.538 |
|
2015 |
Zhu J, Xu X, Hu M, Qiu L. Co-Encapsulation of Combretastatin-A4 Phosphate and Doxorubicin in Polymersomes for Synergistic Therapy of Nasopharyngeal Epidermal Carcinoma. Journal of Biomedical Nanotechnology. 11: 997-1006. PMID 26353589 |
0.335 |
|
Show low-probability matches. |